Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 2,461 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Prospective intervention Clear all

Conditions: Diabetes Mellitus, Diabetic Retinopathy
Interventions: AEYE Software Device; Device
Lead sponsor: AEYE Health Inc; Industry
Eligibility: 22 Years and older
Enrollment: 531 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Interventions: Non-interventional; Other
Lead sponsor: Innoviva Specialty Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 12
States / cities: Sacramento, California • Gainesville, Florida • Tampa, Florida + 9 more

Conditions: Chronic Pain, Depression, PTSD, Injuries, Illness, Chronic, Physical Disability
Interventions: Resilience and Well-Being Program; Behavioral
Lead sponsor: VA Puget Sound Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Joint Diseases, Osteoarthritis, Arthritis Knee, Avascular Necrosis
Interventions: EVOLUTION® NitrX™; Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2035
U.S. locations: 1
States / cities: Fremont, California

Conditions: Sarcopenia
Interventions: Outpatient Muscle Biopsy; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Nail Diseases
Interventions: Suzetrigine, Oxycodone/Acetaminophen, Acetaminophen, Ibuprofen; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Coronary Artery Bypass Grafting
Interventions: Vein Harvesting Procedures; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 16
States / cities: Tucson, Arizona • San Francisco, California • Gainesville, Florida + 13 more

Conditions: Von Willebrand Disease (VWD)
Interventions: VGA039; Drug
Lead sponsor: Vega Therapeutics, Inc; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 14
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 10 more

Conditions: Chronic Constipation, Hirschsprung's Disease
Interventions: Endoscopic Mucosal Resection (EMR); Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 10 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: SIPS the stomach, intestinal, pylorus, sparing procedure; Procedure
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 7
States / cities: Parker, Colorado • Celebration, Florida • Mount Kisco, New York + 4 more

Conditions: Acute Lymphoblastic Leukemia, Brain Tumor
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 3 Years to 21 Years
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC)
Interventions: Blood Draw; Other
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 945 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 23
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 20 more

Conditions: Colorectal and Ileorectal Anastomosis, Colocolic and Ileocolic Anastomosis, Coloanal and Ileoanal Anastomosis
Interventions: Sylys® Surgical Sealant, Stapled Anastomosis Colectomy Procedure; Device · Procedure
Lead sponsor: Cohera Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 16
States / cities: Birmingham, Alabama • Mobile, Alabama • Orange, California + 12 more

Conditions: Choledocholithiasis
Interventions: Initial therapy with papillary balloon dilation, Initial therapy with intraductal lithotripsy; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 115 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Ankyloglossia, Breastfeeding Support
Interventions: Post-frenotomy manual manipulation; Other
Lead sponsor: Georgetown University; Other
Eligibility: Up to 90 Days
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Stress Urinary Incontinence, Pelvic Organ Prolapse
Interventions: Intervention; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2038
U.S. locations: 4
States / cities: New Haven, Connecticut • Durham, North Carolina • Philadelphia, Pennsylvania + 1 more

Conditions: Hypertension
Interventions: Precision Nudging for Hypertension Management; Behavioral
Lead sponsor: Lirio; Industry
Eligibility: 18 Years and older
Enrollment: 12,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Atrial Fibrillation
Interventions: Magnetocardiography; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Urolithiasis, Stones, Kidney, Renal Stones, Kidney Stones
Interventions: CVAC® SYSTEM, FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS), DIRECT IN-SCOPE SUCTION (DISS) IN FLEXIBLE URETEROSCOPY (FURS), URETEROSCOPY (URS) WITHOUT SUCTION, PERCUTANEOUS NEPHROLITHOTOMY (PCNL); Device · Procedure
Lead sponsor: Calyxo, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 10
States / cities: Miami, Florida • Wichita, Kansas • Cheektowaga, New York + 6 more

Conditions: Spinal Diseases
Interventions: Lidocaine local anesthesia- Alternative; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Seroma
Interventions: Microporous Polysaccharide Hemospheres (MPH); Device
Lead sponsor: Memorial Health University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Savannah, Georgia

Conditions: Heart Failure
Interventions: Multidisciplinary team clinic and assessments (Cardiopulmonary exercise test, six-minute-walk-test, MoCA, Quality of Life questionnaires), Caregiver Self-Assessment; Other · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Danon Disease
Interventions: No intervention; Other
Lead sponsor: Rocket Pharmaceuticals Inc.; Industry
Eligibility: 8 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 9
States / cities: Phoenix, Arizona • La Jolla, California • Aurora, Colorado + 6 more

Conditions: Reperfusion Injury, Post Cardiac Arrest Brain Injury
Interventions: LUTICIA - Light Utilization COX-Inhibitory Device); Device
Lead sponsor: Mitovation, Inc; Industry
Eligibility: 48 Hours to 1 Year
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Detroit, Michigan

Search by objective public record fields.

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images

A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

Resilience and Well-Being Pilot Study

Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy

Post-op Analgesia of Nail Unit Procedures

Randomized Endo-Vein Graft Prospective

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease

A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure

European Prospective Investigation Into Childhood Cancer

Prospective Clinicogenomic Program

A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant

Papillary Balloon Dilation Versus Intraductal Lithotripsy

Post-Procedural Manual Manipulation for Infant Ankyloglossia

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

Precision Nudging for Hypertension Management: Observational Study

MCG In Long QT Syndrome

Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study

Cutaneous Administration of Local Anesthetic for Spine Injection Procedures

The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy

Multidisciplinary Ventricular Assist Device Clinic

Danon Disease Natural History Study

Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study). The LUCID Device is Used in the Treatment of Ischemic Brain Reperfusion Injury Caused by Cardiac Arrest in Pediatric Patients.